Lumentum's Q4 Beat and Raise Extends AI Optics Momentum, but Contract Risk Persists
Read source articleWhat happened
Lumentum reported fiscal Q4 revenue of $1.01 billion, up 109% year-over-year, and guided Q1 to more than 130% growth, signaling accelerating AI-driven demand across its optical portfolio. Gross margin hit 50.4% at roughly half the $2 billion quarterly revenue level originally associated with that target, demonstrating strong operating leverage and effective cost management despite ongoing Systems ASP pressure. The growth story is broadening beyond co-packaged optics into 1.6T transceivers, optical circuit switches, CW lasers, NPO, and pump lasers, reducing dependence on any single product cycle. However, the company's SEC filings continue to state that backlog is not a reliable indicator and most customers lack long-term volume commitments, leaving the revenue trajectory vulnerable to order cancellations or delays. Q1 guidance implies revenue near or above $1.1 billion, but the stock's valuation at 168x trailing earnings already reflects much of this near-term momentum.
Implication
The Q4 beat-and-raise confirms that Lumentum is a prime beneficiary of the AI buildout, and the broadening product mix reduces single-cycle risk. Gross margin expansion to 50.4% suggests that cost-down efforts are outpacing ASP declines, which was a key bear concern from the prior quarter. However, the absence of long-term purchase commitments means the current order strength could reverse quickly if hyperscaler capex pauses, as seen in prior cycles. With the stock priced for perfection at 168x earnings, even a slight demand hiccup could trigger a sharp multiple compression, making new entries risky at this level. A more prudent approach is to wait for a pullback toward the $850–$900 range or for tangible evidence of contracted revenue before adding exposure.
Thesis delta
Q4 results materially strengthen the near-term AI demand thesis, as revenue and margin exceeded the high end of guidance and Q1 guidance implies acceleration, shifting the balance of risks away from an imminent air-pocket. That said, the company's own 10-Q language on unreliable backlog and lack of long-term commitments prevents an upgrade to a Buy without either contracted visibility or a better entry point. The WAIT rating holds, but the bull case's probability has increased, and the attractive entry level may need to be revised upward.
Confidence
High